Hutch News

Hutch News

Stories tagged 'bone marrow'

Could a prostate cancer drug save lives from radiation injury?

Early research shows potential for approved hormone-blocking drug to protect from deadly effects of nuclear blast

Jan. 9, 2018 | By Susan Keown / Fred Hutch News Service

A new study used a hormone-blocking prostate cancer drug called degarelix to save the lives of mice exposed to a deadly level of radiation. Could it do the same for people caught in a nuclear blast?

View story >

Dr. Hans-Peter Kiem

'He really wanted to fight this cancer': A stem cell researcher remembers his first patient in a gene therapy clinical trial

Feb. 24, 2016 | By Dr. Hans-Peter Kiem, as told to Mary Engel

"He really wanted to fight this cancer": A stem cell researcher remembers his first patient in a gene therapy clinical trial for a deadly brain cancer and reflects on his own journey toward translating science into medical treatments.

View story >

Dramatic remissions seen in immunotherapy trial of blood cancer patients

Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care

Feb. 16, 2016 | By Andrea Detter / Fred Hutch News Service

Many patients with advanced blood cancers who are receiving experimental, “living” immunotherapy as part of a clinical trial are experiencing sustained remissions, according to preliminary results of the ongoing study at Fred Hutchinson Cancer Research Center.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.